Clinical Trials

Clinical trials and studies about imaging technology can be found on this channel.

Shorter treatment course found as effective as longer schedule for people with non-HPV-related locally advanced disease

Accelerated Radiation Treatment Could Reduce Head and Neck Cancer Patient Burden in Low- and Middle-income Countries

October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income ...

October 02, 2023

Multi-center study achieves durable local control and cancer-specific survival after stereotactic radiation treatment

News | Stereotactic Body Radiation Therapy (SBRT)

High-dose Radiation Offers New Treatment Option for Older Patients with Inoperable Kidney Tumors

October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted ...

October 01, 2023

Beilinson Hospital in Israel used Nanox.AI’s HealthCCSng solution to conduct study on routine chest CT scans to assess impact of AI-based coronary artery calcium (CAC) measurements

News | Computed Tomography (CT)

Nanox.AI’s HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

September 29, 2023

Phase III trial finds fewer, higher doses cut treatment time while maintaining high rates of cure

News | Prostate Cancer

SBRT as Effective as Conventional Radiation for People with Intermediate Risk, Localized Prostate Cancer

September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer ...

September 29, 2023

Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy

News | Breast Imaging

Combination Radiation with Immunotherapy Shows Promise Against “Cold” Breast Cancer Tumors

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

September 27, 2023

Medical imaging artificial intelligence (AI) company Annalise.ai has announced that results from a pioneering clinical study, which examined whether its technology improves radiologists’ performance, have been published in the journal European Radiology.

News | Artificial Intelligence

Study Shows Annalise Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

September 20, 2023

Lunit's collaborative study supports AI as a viable alternative to one human reader in Europe’s double reading system - published in The Lancet Digital Health

News | Artificial Intelligence

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

September 11, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is ...

September 11, 2023

The clinical study of Positron’s Affinity PET-CT is designed to provide key information that evaluate the new system and its full capabilities with multiple radiopharmaceuticals and new coronary flow software applications that will enhance physician’s diagnostic analysis

News | PET-CT

Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

September 08, 2023

STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023

News | Clinical Trials

Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...

August 28, 2023

Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research from UCL, UCLH and King’s College London

News | Prostate Cancer

MRI Scans Improve Prostate Cancer Diagnosis in Screening Trial

August 22, 2023 — Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been ...

August 22, 2023

AI enhancing Cedars-Sinai patient care, clinical and research initiatives, and medical discoveries

News | Artificial Intelligence

Cedars-Sinai Charts Healthcare’s Future With Artificial Intelligence

August 18, 2023 — Artificial intelligence (AI) is capturing the public imagination as the pace of innovation accelerates ...

August 18, 2023

Automated abdominal adipose tissue segmentation into SAT, VAT via Dixon MRI in different children

News | Magnetic Resonance Imaging (MRI)

Automated DL Segmentation of Adolescent Abdominal Adipose Tissue on Dixon MRI

August 18, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR), an ...

August 18, 2023

The trial, led by researchers from Lund University in Sweden, has been published in The Lancet Oncology

News | Mammography

AI-supported Mammography Screening is Found to be Safe

August 2, 2023 — Mammography screening supported by artificial intelligence (AI) is a safe alternative to today’s ...

August 02, 2023

FAU Nursing researchers examine mammography screening frequency, perceptions and beliefs in an underserved population

News | Breast Imaging

Study Uncovers Barriers to Mammography Screening Among Black Women

August 1, 2023 — Breast cancer health disparities disproportionately impact Black/African American women in the United ...

August 01, 2023

News | Radiology Business

TAE Life Sciences Promotes Rob Hill to CEO

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

July 27, 2023

A collaboration to advance development of a fibroblast activation protein (FAP)-targeted PET diagnostic compound for a broad array of epithelial-derived cancers.

News | Radiopharmaceuticals and Tracers

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

July 25, 2023

News | Contrast Media

Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions

July 25, 2023 — Bracco Imaging has issued a statement on new results published in the journal Radiology which found that ...

July 25, 2023

Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials

Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA

The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

July 11, 2023

Comprehensive clinical development program called QUANTI includes two Phase III studies in adults and one pediatric study investigating gadoquatrane for use in MRI across all body regions and across ages from birth to adulthood

News | Contrast Media

Bayer initiates Phase III Studies with Investigational Contrast Agent Gadoquatrane

July 7, 2023 — Bayer, a global leader in radiology, has initiated the Phase III clinical development program called ...

July 06, 2023

Preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage

News | Contrast Media

Switch to MR Angiography for PE Mitigated Impact of Recent Contrast Shortage

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

July 03, 2023